Hemodialysis

Fluid, Electrolyte and Acid-Base Disorders in Small Animal Practice

Volumn , Issue , 2006, Pages 650-677

  Cowgill, Larry D ^a   Francey, Thierry ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882370836     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B0-72-163949-6/50032-1     Document Type: Chapter

References (157)

1. Abel JJ, Rowntree LC, Turner BB On the removal of diffusible substances from the circulating blood by means of dialysis. Trans Assoc Am Physiol 1913, 28:41.
2. Adin CA Screening criteria for feline renal transplant recipients and donors. Clin Tech Small Anim Pract 2002, 17:184-189.
3. Adin CA, Cowgill LD Treatment and outcome of dogs with leptospirosis: 36 cases (1990-1998). J Am Vet Med Assoc 2000, 216:371-375.
4. Adin CA, Gregory CR, Kyles AE, et al. Diagnostic predictors of complications and survival after renal transplantation in cats. Vet Surg 2001, 30:515-521.
5. Agostoni PG, Marenzi GC Sustained benefit from ultrafiltration in moderate congestive heart failure. Cardiology 2001, 96:183-189.
6. Al-Hilali N, Al-Humoud HM, Ninan VT, et al. Profiled hemodialysis reduces intradialytic symptoms. Transplant Proc 2004, 36:1827-1828.
7. Arieff AI More on the dialysis disequilibrium syndrome. West J Med 1989, 151:74-76.
8. Arieff AI Dialysis disequilibrium syndrome: current concepts on pathogenesis and prevention. Kidney Int 1994, 45:629-635.
9. Arieff AI, Guisado R, Massry SG, et al. Central nervous system pH in uremia and the effects of hemodialysis. J Clin Invest 1976, 58:306-311.
10. Arieff AI, Lazarowitz VC, Guisado R Experimental dialysis disequilibrium syndrome: prevention with glycerol. Kidney Int 1978, 14:270-278.
11. Arieff AI, Mahoney CA Pathogenesis of dialysis encephalopathy. Neurobehav Toxicol Teratol 1983, 5:641-644.
12. Bankhead MM, Toto RD, Star RA Accuracy of urea removal estimated by kinetic models. Kidney Int 1995, 48:785-793.
13. Behrend EN, Grauer GF, Mani I, et al. Hospital-acquired acute renal failure in dogs: 29 cases (1983-1992). J Am Vet Med Assoc 1996, 208:537-541.
14. Bellomo R, Ronco C Continuous haemofiltration in the intensive care unit. Crit Care 2000, 4:339-345.
15. Bernsteen L, Gregory CR, Kyles AE, et al. Renal transplantation in cats. Clin Tech Small Anim Pract 2000, 15:40-45.
16. Biasioli S, D'Andrea G, Feriani M, et al. Uremic encephalopathy: an updating. Clin Nephrol 1986, 25:57-63.
17. Blake PG Adequacy of dialysis revisited. Kidney Int 2003, 63:1587-1599.
18. Boure T, Vanholder R Biochemical and clinical evidence for uremic toxicity. Artif Organs 2004, 28:248-253.
19. Brunet P, Dou L, Cerini C, et al. Protein-bound uremic retention solutes. Adv Ren Replace Ther 2003, 10:310-320.
20. Carvalho KT, Silva MI, Bregman R Nutritional profile of patients with chronic renal failure. J Ren Nutr 2004, 14:97-100.
21. Casino FG, Lopez T The equivalent renal urea clearance: a new parameter to assess dialysis dose. Nephrol Dial Transplant 1996, 11:1574-1581.
22. Casino FG, Marshall MR Simple and accurate quantification of dialysis in acute renal failure patients during either urea non-steady state or treatment with irregular or continuous schedules. Nephrol Dial Transplant 2004, 19:1454-1466.
23. Chang IJ, Fischach BV, Sile S, et al. Extracorporeal treatment of poisoning. Brenner and Rector's the kidney 2004, 2733-2757. WB Saunders, Philadelphia. B.M. Brenner (Ed.).
24. Charra B, Calemard E, Ruffet M, et al. Survival as an index of adequacy of dialysis. Kidney Int 1992, 41:1286-1291.
25. Chow MT, Di Silvestro VA, Yung CY, et al. Treatment of acute methanol intoxication with hemodialysis using an ethanol-enriched, bicarbonate-based dialysate. Am J Kidney Dis 1997, 30:568-570.
26. Clark W, Winchester J Middle molecules and small molecular weight proteins in ESRD: properties and strategies for their removal. Adv Ren Replace Ther 2003, 10:270-278.
27. Coli L, Ursino M, Donati G, et al. Clinical application of sodium profiling in the treatment of intradialytic hypotension. Int J Artif Organs 2003, 26:715-722.
28. Cooper BA, Aslani A, Ryan M, et al. Comparing different methods of assessing body composition in end-stage renal failure. Kidney Int 2000, 58:408-416.
29. Cowgill LD, Elliott DA Hemodialysis. Fluid therapy in small animal practice 2000, 528-547. WB Saunders, Philadelphia. S.P. DiBartola (Ed.).
30. Cowgill LD, Francey T Acute uremia. Textbook of veterinary internal medicine: diseases of the dog and cat 2004, 1731-1751. WB Saunders, Philadelphia. S.J. Ettinger, E.C. Feldman (Eds.).
31. Cowgill LD, Langston CE Role of hemodialysis in the management of dogs and cats with renal failure. Vet Clin North Am Small Anim Pract 1996, 26:1347-1378.
32. Daugirdas JT The post:pre-dialysis plasma urea nitrogen ratio to estimate K.t/V and NPCR: mathematical modeling. Int J Artif Organs 1989, 12:411-419.
33. Daugirdas JT Dialysis hypotension: a hemodynamic analysis. Kidney Int 1991, 39:233-246.
34. Daugirdas JT, Van Stone JC Physiologic principles and urea kinetic modeling. Handbook of dialysis 2001, 15-45. Lippincott Williams & Wilkins, Philadelphia. J.T. Daugirdas, P.G. Blake, T.S. Ing (Eds.).
35. De Nicola L, Bellizzi V, Minutolo R, et al. Effect of dialysate sodium concentration on interdialytic increase of potassium. J Am Soc Nephrol 2000, 11:2337-2343.
36. De Vries JP, Donker AJ, De Vries PM Prevention of hypovolemia-induced hypotension during hemodialysis by means of an optical reflection method. Int J Artif Organs 1994, 17:209-214.
37. de Vries JP, Kouw PM, van der Meer NJ, et al. Non-invasive monitoring of blood volume during hemodialysis: its relation with post-dialytic dry weight. Kidney Int 1993, 44:851-854.
38. Depner T Benefits of more frequent dialysis: lower TAC at the same Kt/V. Nephrol Dial Transplant 1998, 13:20-24.
39. Depner TA Prescribing hemodialysis: a guide to urea modeling 1990, Kluwer Academic Publishers, Boston.
40. Depner TA Uremic toxicity: urea and beyond. Semin Dial 2001, 14:246-251.
41. Depner TA, Bhat A Quantifying daily hemodialysis. Semin Dial 2004, 17:79-84.
42. Depner TA, Gotch FA, Port FK, et al. How will the results of the HEMO study impact dialysis practice?. Semin Dial 2003, 16:8-21.
43. Di Filippo S, Manzoni C, Andrulli S, et al. How to determine ionic dialysance for the online assessment of delivered dialysis dose. Kidney Int 2001, 59:774-782.
44. Di Filippo S, Manzoni C, Andrulli S, et al. Ionic dialysance allows an adequate estimate of urea distribution volume in hemodialysis patients. Kidney Int 2004, 66:786-791.
45. DuBose TD, Warnock DG, Mehta RL, et al. Acute renal failure in the 21st century: recommendations for management and outcomes assessment. Am J Kidney Dis 1997, 29:793-799.
46. Eknoyan G, Beck GJ, Cheung AK, et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 2002, 347:2010-2019.
47. Eustace JA, Astor B, Muntner PM, et al. Prevalence of acidosis and inflammation and their association with low serum albumin in chronic kidney disease. Kidney Int 2004, 65:1031-1040.
48. Feriani M Behaviour of acid-base control with different dialysis schedules. Nephrol Dial Transplant 1998, 13(suppl 6):62-65.
49. Fischer JR, Pantaleo V, Francey T, et al. Veterinary hemodialysis: advances in management and technology. Vet Clin North Am Small Anim Pract 2004, 34:935-967. vi-vii.
50. Flanigan MJ Role of sodium in hemodialysis. Kidney Int Suppl 2000, 76:S72-S78.
51. Francey T, Benitah N, Pantaleo V, et al. Use of combined hemoperfusion and hemodialysis in accidental enrofloxacin overdose. 2004 ACVIM Forum Proceedings 2004, 18:441-442.
52. Francey T, Cowgill LD Use of hemodialysis for the management of ARF in the dog: 124 cases (1990-2001). J Vet Intern Med 2002, 16:352.
53. Friedman AN, Jaber BL Dialysis adequacy in patients with acute renal failure. Curr Opin Nephrol Hypertens 1999, 8:695-700.
54. Goldstein DJ, Frederico CB The effect of urea kinetic modeling on the nutrition management of hemodialysis patients. J Am Diet Assoc 1987, 87:474-479.
55. Gotch FA Evolution of the single-pool urea kinetic model. Semin Dial 2001, 14:252-256.
56. Gotch FA Is Kt/V urea a satisfactory measure for dosing the newer dialysis regimens?. Semin Dial 2001, 14:15-17.
57. Gotch FA, Panlilio FM, Buyaki RA, et al. Mechanisms determining the ratio of conductivity clearance to urea clearance. Kidney Int Suppl 2004, S3-S24.
58. Guh JY, Yang CY, Yang JM, et al. Prediction of equilibrated postdialysis BUN by an artificial neural network in high-efficiency hemodialysis. Am J Kidney Dis 1998, 31:638-646.
59. Hakim RM, Breyer J, Ismail N, et al. Effects of dose of dialysis on morbidity and mortality. Am J Kidney Dis 1994, 23:661-669.
60. Hakim RM, Depner TA, Parker TF Adequacy of hemodialysis. Am J Kidney Dis 1992, 20:107-123.
61. Heidenheim AP, Muirhead N, Moist L, et al. Patient quality of life on quotidian hemodialysis. Am J Kidney Dis 2003, 42:36-41.
62. Heiene R, Vulliet PR, Williams RL, et al. Use of capillary electrophoresis to quantitate carbamylated hemoglobin concentrations in dogs with renal failure. Am J Vet Res 2001, 62:1302-1306.
63. Held PJ, Port FK, Wolfe RA, et al. The dose of hemodialysis and patient mortality. Kidney Int 1996, 50:550-556.
64. Henle T, Miyata T Advanced glycation end products in uremia. Adv Ren Replace Ther 2003, 10:321-331.
65. Henrich WL Hemodynamic instability during hemodialysis. Kidney Int 1986, 30:605-612.
66. Ikizler TA, Schulman G Adequacy of dialysis. Kidney Int Suppl 1997, 62:S96-S100.
67. Ishibe S, Peixoto AJ Methods of assessment of volume status and intercompartmental fluid shifts in hemodialysis patients: implications in clinical practice. Semin Dial 2004, 17:37-43.
68. Jaeger JQ, Mehta RL Assessment of dry weight in hemodialysis: an overview. J Am Soc Nephrol 1999, 10:392-403.
69. Jaffrin MY, Fenech M, de Fremont JF, et al. Continuous monitoring of plasma, interstitial, and intracellular fluid volumes in dialyzed patients by bioimpedance and hematocrit measurements. ASAIO J 2002, 48:326-333.
70. Johnson WJ, Hagge WW, Wagoner RD, et al. Effects of urea loading in patients with far-advanced renal failure. Mayo Clin Proc 1972, 47:21-29.
71. Kanagasundaram NS, Greene T, Larive AB, et al. Prescribing an equilibrated intermittent hemodialysis dose in intensive care unit acute renal failure. Kidney Int 2003, 64:2298-2310.
72. Kaysen GA The microinflammatory state in uremia: causes and potential consequences. J Am Soc Nephrol 2001, 12:1549-1557.
73. Kaysen GA Role of inflammation and its treatment in ESRD patients. Blood Purif 2002, 20:70-80.
74. Kaysen GA, Kumar V Inflammation in ESRD: causes and potential consequences. J Ren Nutr 2003, 13:158-160.
75. Kloppenburg WD, Stegeman CA, Hooyschuur M, et al. Assessing dialysis adequacy and dietary intake in the individual hemodialysis patient. Kidney Int 1999, 55:1961-1969.
76. Kosanovich JM, Dumler F, Horst M, et al. Use of urea kinetics in the nutritional care of the acutely ill patient. J Parenter Enteral Nutr 1985, 9:165-169.
77. Kuhlmann U, Goldau R, Samadi N, et al. Accuracy and safety of online clearance monitoring based on conductivity variation. Nephrol Dial Transplant 2001, 16:1053-1058.
78. Lambie SH, McIntyre CW Developments in online monitoring of haemodialysis patients: towards global assessment of dialysis adequacy. Curr Opin Nephrol Hypertens 2003, 12:633-638.
79. Langston CE, Cowgill LD, Spano JA Applications and outcome of hemodialysis in cats: a review of 29 cases. J Vet Intern Med 1997, 11:348-355.
80. Lesaffer G, De Smet R, D'Heuvaert T, et al. Comparative kinetics of the uremic toxin p-cresol versus creatinine in rats with and without renal failure. Kidney Int 2003, 64:1365-1373.
81. Lindsay RM, Leitch R, Heidenheim AP, et al. The London Daily/Nocturnal Hemodialysis Study-study design, morbidity, and mortality results. Am J Kidney Dis 2003, 42:5-12.
82. Locatelli F, Buoncristiani U, Canaud B, et al. Haemodialysis with on-line monitoring equipment: tools or toys?. Nephrol Dial Transplant 2005, 20:22-33.
83. Locatelli F, Covic A, Chazot C, et al. Optimal composition of the dialysate, with emphasis on its influence on blood pressure. Nephrol Dial Transplant 2004, 19:785-796.
84. Lopot F, Valek A Time-averaged concentration-time-averaged deviation: a new concept in mathematical assessment of dialysis adequacy. Nephrol Dial Transplant 1988, 3:846-848.
85. Lowrie E, Lew N The urea reduction ratio (URR): a simple method for evaluating hemodialysis treatment. Contemp Dial Nephrol 1991, 12:11-20.
86. Lowrie EG, Laird NM, Parker TF, et al. Effect of the hemodialysis prescription of patient morbidity: report from the National Cooperative Dialysis Study. N Engl J Med 1981, 305:1176-1181.
87. Maggiore Q Isothermic dialysis for hypotension-prone patients. Semin Dial 2002, 15:187-190.
88. Maggiore Q, Pizzarelli F, Santoro A, et al. The effects of control of thermal balance on vascular stability in hemodialysis patients: results of the European randomized clinical trial. Am J Kidney Dis 2002, 40:280-290.
89. Marenzi G, Lauri G, Grazi M, et al. Circulatory response to fluid overload removal by extracorporeal ultrafiltration in refractory congestive heart failure. J Am Coll Cardiol 2001, 38:963-968.
90. Mawby DI, Bartges JW, D'Avignon A, et al. Comparison of various methods for estimating body fat in dogs. J Am Anim Hosp Assoc 2004, 40:109-114.
91. Mehta RL, McDonald B, Gabbai FB, et al. A randomized clinical trial of continuous versus intermittent dialysis for acute renal failure. Kidney Int 2001, 60:1154-1163.
92. Messa P, Gropuzzo M, Cleva M, et al. Behaviour of phosphate removal with different dialysis schedules. Nephrol Dial Transplant 1998, 13(suppl 6):43-48.
93. Michael M, Brewer ED, Goldstein SL Blood volume monitoring to achieve target weight in pediatric hemodialysis patients. Pediatr Nephrol 2004, 19:432-437.
94. Michel KE, Sorenmo K, Shofer FS Evaluation of body condition and weight loss in dogs presented to a veterinary oncology service. J Vet Intern Med 2004, 18:692-695.
95. Miyata T, Saito A, Kurokawa K, et al. Advanced glycation and lipoxidation end products: reactive carbonyl compounds-related uraemic toxicity. Nephrol Dial Transplant 2001, 16(suppl 4):8-11.
96. Mujais SK, Schmidt B Operating characteristics of hollow-fiber dialyzers. Clinical dialysis 1995, 77-92. Appleton & Lange, Norwalk, CT. A.R. Nissensen, R.N. Fine, D.E. Gentile (Eds.).
97. NKF I. NKF-K/DOQI Clinical Practice Guidelines for Hemodialysis Adequacy: update 2000. Am J Kidney Dis 2001, 37:S7-S64.
98. Noghnogh AA, Reid RW, Nawab ZM, et al. Preparation of ethanol-enriched, bicarbonate-based hemodialysates. Artif Organs 1999, 23:208-209.
99. Oberg BP, McMenamin E, Lucas FL, et al. Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. Kidney Int 2004, 65:1009-1016.
100. Owen WF, Lew NL, Liu Y, et al. The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 1993, 329:1001-1006.
101. Palmer CA Neurologic manifestations of renal disease. Neurol Clin 2002, 20:23-34. v.
102. Pantaleo V, Francey T, Cowgill LD: Analysis of hyperkalemia in dogs on chronic hemodialysis, ACVIM Forum 2005, Baltimore, MD, 2005.
103. Pantaleo V, Francey T, Fischer JR, et al. Application of hemodialysis for the management of acute uremia in cats: 119 cases (1993-2003). J Vet Intern Med 2004, 18:418.
104. Parker TF, Husni L, Huang W, et al. Survival of hemodialysis patients in the United States is improved with a greater quantity of dialysis. Am J Kidney Dis 1994, 23:670-680.
105. Pedrini LA, Zereik S, Rasmy S Causes, kinetics and clinical implications of post-hemodialysis urea rebound. Kidney Int 1988, 34:817-824.
106. Pergola PE, Habiba NM, Johnson JM Body temperature regulation during hemodialysis in long-term patients: is it time to change dialysate temperature prescription?. Am J Kidney Dis 2004, 44:155-165.
107. Petitclerc T Festschrift for Professor Claude Jacobs. Recent developments in conductivity monitoring of haemodialysis session. Nephrol Dial Transplant 1999, 14:2607-2613.
108. Polaschegg HD Automatic, noninvasive intradialytic clearance measurement. Int J Artif Organs 1993, 16:185-191.
109. Polzin DJ, Osborne CA, Ross S Chronic kidney disease. Textbook of veterinary internal medicine 2004, 1756-1776. WB Saunders, Philadelphia. S.J. Ettinger, E.C. Feldman (Eds.).
110. Redaelli B Electrolyte modelling in haemodialysis-potassium. Nephrol Dial Transplant 1996, 11(suppl 2):39-41.
111. Redaelli B Hydroelectrolytic equilibrium change in dialysis. J Nephrol 2001, 14(suppl 4):S7-S11.
112. Redaelli B, Bonoldi G, Di Filippo G, et al. Behaviour of potassium removal in different dialytic schedules. Nephrol Dial Transplant 1998, 13(suppl 6):35-38.
113. Rollings CE, Francey T, Cowgill LD Use of hemodialysis in uremic and non-uremic dogs with ethylene glycol toxicity. J Vet Intern Med 2004, 18:416.
114. Ronco C, Ricci Z, Brendolan A, et al. Ultrafiltration in patients with hypervolemia and congestive heart failure. Blood Purif 2004, 22:150-163.
115. Rosales LM, Schneditz D, Morris AT, et al. Isothermic hemodialysis and ultrafiltration. Am J Kidney Dis 2000, 36:353-361.
116. Sargent JA, Gotch FA Mathematic modeling of dialysis therapy. Kidney Int Suppl 1980, 10:S2-S10.
117. Sargent JA, Gotch FA Principles and biophysics of dialysis. Replacement of renal function by dialysis: a textbook of dialysis 1989, 87-143. Kluwer Academic Publishers, Boston. J.F. Maher (Ed.).
118. Sargent JA, Lowrie EG Which mathematical model to study uremic toxicity? National Cooperative Dialysis Study. Clin Nephrol 1982, 17:303-314.
119. Schneditz D, Daugirdas JT Compartment effects in hemodialysis. Semin Dial 2001, 14:271-277.
120. Schneditz D, Ronco C, Levin N Temperature control by the blood temperature monitor. Semin Dial 2003, 16:477-482.
121. Schroeder KL, Sallustio JE, Ross EA Continuous haematocrit monitoring during intradialytic hypotension: precipitous decline in plasma refill rates. Nephrol Dial Transplant 2004, 19:652-656.
122. Schulman G, Himmelfarb J Hemodialysis. Brenner & Rector's the kidney 2004, 2564-2624. WB Saunders, Philadelphia. B.M. Brenner (Ed.).
123. Shackman R, Chisholm GD, Holden AJ, et al. Urea distribution in the body after haemodialysis. BMJ 1962, 5301:355-358.
124. Sharma A, Espinosa P, Bell L, et al. Multicompartment urea kinetics in well-dialyzed children. Kidney Int 2000, 58:2138-2146.
125. Sheppard R, Panyon J, Pohwani AL, et al. Intermittent outpatient ultrafiltration for the treatment of severe refractory congestive heart failure. J Card Fail 2004, 10:380-383.
126. Sherman RA Modifying the dialysis prescription to reduce intradialytic hypotension. Am J Kidney Dis 2001, 38:S18-S25.
127. Sherman RA, Cody RP, Rogers ME, et al. Accuracy of the urea reduction ratio in predicting dialysis delivery. Kidney Int 1995, 47:319-321.
128. Shinaberger JH Quantitation of dialysis: historical perspective. Semin Dial 2001, 14:238-245.
129. Sigdell JE, Tersteegen B Clearance of a dialyzer under varying operating conditions. Artif Organs 1986, 10:219-225.
130. Silver SM, DeSimone JA, Smith DA, et al. Dialysis disequilibrium syndrome (DDS) in the rat: role of the "reverse urea effect,". Kidney Int 1992, 42:161-166.
131. Silver SM, Sterns RH, Halperin ML Brain swelling after dialysis: old urea or new osmoles?. Am J Kidney Dis 1996, 28:1-13.
132. Smye SW, Hydon PE, Will E An analysis of the single-pool urea kinetic model and estimation of errors. Phys Med Biol 1993, 38:115-122.
133. Smye SW, Tattersall JE, Will EJ Modeling the postdialysis rebound: the reconciliation of current formulas. ASAIO J 1999, 45:562-567.
134. Song JH, Park GH, Lee SY, et al. Effect of sodium balance and the combination of ultrafiltration profile during sodium profiling hemodialysis on the maintenance of the quality of dialysis and sodium and fluid balances. J Am Soc Nephrol 2005, 16:237-246.
135. Steuer RR, Bell DA, Barrett LL Optical measurement of hematocrit and other biological constituents in renal therapy. Adv Ren Replace Ther 1999, 6:217-224.
136. Steuer RR, Harris DH, Weiss RL, et al. Evaluation of a noninvasive hematocrit monitor: a new technology. Am Clin Lab 1991, 10:20-22.
137. Stiller S, Bonnie-Schorn E, Grassmann A, et al. A critical review of sodium profiling for hemodialysis. Semin Dial 2001, 14:337-347.
138. Suri R, Depner TA, Blake PG, et al. Adequacy of quotidian hemodialysis. Am J Kidney Dis 2003, 42:42-48.
139. Suri RS, Depner T, Lindsay RM Dialysis prescription and dose monitoring in frequent hemodialysis. Contrib Nephrol 2004, 145:75-88.
140. Thrall M Advances in therapy for antifreeze poisoning. Calif Vet 1998, 52:18-22.
141. Vaden SL, Levine J, Breitschwerdt EB A retrospective case-control of acute renal failure in 99 dogs. J Vet Intern Med 1997, 11:58-64.
142. Vanholder R, De Smet R, Glorieux G, et al. Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int 2003, 63:1934-1943.
143. Vanholder R, Glorieux G, De Smet R, et al. Low water-soluble uremic toxins. Adv Ren Replace Ther 2003, 10:257-269.
144. Vanholder R, Glorieux G, De Smet R, et al. New insights in uremic toxins. Kidney Int 2003, 63:S6-S10.
145. Vanholder R, Winchester J Introduction: uremic toxins. Adv Ren Replace Ther 2003, 10:256.
146. Vanholder RC, Glorieux GL An overview of uremic toxicity. Hemodial Int 2003, 7:156-161.
147. Vanholder RC, Glorieux GL, De Smet RV Uremic toxins: removal with different therapies. Hemodial Int 2003, 7:162-167.
148. Vinay P, Cardoso M, Tejedor A, et al. Acetate metabolism during hemodialysis: metabolic considerations. Am J Nephrol 1987, 7:337-354.
149. Winchester JF Dialysis and hemoperfusion in poisoning. Adv Ren Replace Ther 2002, 9:26-30.
150. Wolf AV, Remp DG, Kiley JE, et al. Artificial kidney function; kinetics of hemodialysis. J Clin Invest 1951, 30:1062-1070.
151. Yeun JY, Depner TA Complications related to inadequate delivered dose: recognition and management in acute and chronic dialysis. Complications of dialysis 2000, 89-115. Marcel Dekker, Inc., New York. N. Lameire, R.L. Mehta (Eds.).
152. Zhu F, Kuhlmann MK, Sarkar S, et al. Adjustment of dry weight in hemodialysis patients using intradialytic continuous multifrequency bioimpedance of the calf. Int J Artif Organs 2004, 27:104-109.
153. Zhu F, Sarkar S, Kaitwatcharachai C, et al. Methods and reproducibility of measurement of resistivity in the calf using regional bioimpedance analysis. Blood Purif 2003, 21:131-136.
154. Grollman EF, Grollman A Toxicity of urea and its role in the pathogenesis of uremia. J Clin Invest 1959, 38:749-754.
155. Laird NM, Berkey CS, Lowrie EG Modeling success or failure of dialysis therapy: the National Cooperative Dialysis Study. Kidney Int Suppl 1983, Apr:S101-S106.
156. Levine J, Bernard DB The role of urea kinetic modeling, TACurea, and Kt/V in achieving optimal dialysis: a critical reappraisal. Am J Kidney Dis 1990, 15:285-301.
157. Lowrie EG, Teehan BP Principles of prescribing dialysis therapy: implementing recommendations from the National Cooperative Dialysis Study. Kidney Int Suppl 1983, Apr:S113-S122.